Edition:
United Kingdom

Aileron Therapeutics Inc (ALRN.OQ)

ALRN.OQ on NASDAQ Stock Exchange Global Market

0.59USD
16 Aug 2019
Change (% chg)

$-0.01 (-1.01%)
Prev Close
$0.60
Open
$0.62
Day's High
$0.62
Day's Low
$0.57
Volume
86,743
Avg. Vol
48,085
52-wk High
$4.07
52-wk Low
$0.46

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2019 Jun '19 0.00 -0.261
Mar '19 0.00 -0.487
FY 2018 Dec '18 0.00 -0.477
Sep '18 0.00 -0.504
Jun '18 0.00 -0.644
Mar '18 0.00 -0.515
FY 2017 Dec '17 0.00 -0.466
Sep '17 0.00 -0.425
Jun '17 0.00 -0.336
Mar '17 0.00 -0.311
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Quarter Ending Sep-19 3 0.00 0.00 0.00 0.00
Quarter Ending Dec-19 3 0.00 0.00 0.00 0.00
Year Ending Dec-19 3 0.00 0.00 0.00 0.00
Year Ending Dec-20 4 0.00 0.00 0.00 50.82
Earnings (per share)
Quarter Ending Sep-19 3 -0.22 -0.19 -0.26 -0.68
Quarter Ending Dec-19 3 -0.23 -0.19 -0.26 -0.70
Year Ending Dec-19 3 -1.10 -0.96 -1.27 -2.38
Year Ending Dec-20 4 -0.86 -0.80 -0.91 -1.45
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 69.38 32.67
P/E High - Last 5 Yrs. -- 147.67 47.29
P/E Low - Last 5 Yrs. -- 47.98 23.87
Beta -- 1.09 0.89
Price to Sales (TTM) -- 49.45 7.91
Price to Book (MRQ) -- 10.14 5.38
Price to Tangible Book (MRQ) 22.32 13.74 6.71
Price to Cash Flow (TTM) -- 55.94 24.37
% Owned Institutions 37.48 3.66 1.45

Dividends

  Company industry sector
Dividend Yield -- 0.12 1.35
Dividend Yield - 5 Year Avg -- 0.09 1.38
Dividend 5 Year Growth Rate -- 0.78 4.54
Payout Ratio(TTM) -- 7.01 40.24

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago -- 205.61 12.23
Sales (TTM) vs TTM 1 Yr. Ago -- 49.06 7.74
Sales - 5 Yr. Growth Rate -- 22.79 10.88
EPS (MRQ) vs Qtr. 1 Yr. Ago 10.99 75.23 42.99
EPS (TTM) vs TTM 1 Yr. Ago -13.60 -- --
EPS - 5 Yr. Growth Rate -- 11.92 10.32
Capital Spending - 5 Yr. Growth Rate -- 9.20 14.84

Financial Strength

  Company industry sector
Quick Ratio (MRQ) -- 2.23 2.21
Current Ratio (MRQ) 2.19 3.59 3.03
LT Debt to Equity (MRQ) 0.00 18.57 10.20
Total Debt to Equity (MRQ) 0.00 31.18 14.55
Interest Coverage (TTM) -- -44.60 29.80

Profitability Ratios

  Company industry sector
Gross Margin (TTM) -- 56.08 52.25
Gross Margin - 5 Yr. Avg. -- 60.28 50.41
EBITD Margin (TTM) -- -- --
EBITD - 5 Yr. Avg -- -110.38 13.13
Operating Margin (TTM) -- -184.16 6.92
Operating Margin - 5 Yr. Avg. -- -126.82 8.94
Pre-Tax Margin (TTM) -- -174.91 6.13
Pre-Tax Margin - 5 Yr. Avg. -- -132.58 9.23
Net Profit Margin (TTM) -- -181.60 2.76
Net Profit Margin - 5 Yr. Avg. -- -136.95 5.60
Effective Tax Rate (TTM) -- 22.42 22.40
Effective Tax Rate - 5 Yr. Avg. -- 15.43 22.74

Efficiency

  Company industry sector
Revenue/Employee (TTM) 0 7,668,825 887,145,970
Net Income/Employee (TTM) -1,209,600 533,853 101,828,577
Receivable Turnover (TTM) -- 6.28 5.93
Inventory Turnover (TTM) -- 1.88 3.36
Asset Turnover (TTM) -- 0.32 0.94

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -- 6.40 11.17
Return on Assets - 5 Yr. Avg. -- 5.49 12.34
Return on Investment (TTM) -- 8.94 14.48
Return on Investment - 5 Yr. Avg. -- 6.81 16.02
Return on Equity (TTM) -- 10.07 15.78
Return on Equity - 5 Yr. Avg. -- 8.38 17.01
  1 Year 3 Year 5 Year
Sales % -- -- --
EPS (TTM) % -40.54 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for Aileron Therapeutics Inc

Period %
Actual
% vs.
S&P 500
Rank In
Industry
Industry
Rank
4 Week 4.36 0.76 55 99
13 Week 5.87 0.71 59 95
26 Week -- -- -- 97
52 Week -- -- -- 71
YTD -- -- -- 73
Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 30.12%
# of Holders: 30
Total Shares Held: 8,377,293
3 Mo. Net Change: 864,285
# New Positions: 5
# Closed Positions: 5
# Increased Positions: 14
# Reduced Positions: 10
# Net Buyers: 4
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.